Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Nervous SystemDRG 056-degenerative-nervous-system-disorders-with-mcc
    Ask Trek AI about this page

    Degenerative Nervous System Disorders with MCC: Inpatient Reimbursement Overview

    DRG 056 encompasses degenerative nervous system disorders complicated by a Major Complication or Comorbidity, indicating higher resource needs during hospitalization. It matters for inpatient reimbursement because the Major Complication or Comorbidity status elevates the Diagnosis-Related Group assignment and influences Medicare payment under the inpatient prospective payment framework.

    Customize your policy alerts

    Sign up for drg 056 policy alerts

    Get alerted when payer policies referencing 056 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 056 Overview

    DRG 056 covers hospital admissions for degenerative nervous system disorders with a Major Complication or Comorbidity present, typically including advanced neurodegenerative conditions such as Parkinson disease with severe complications, amyotrophic lateral sclerosis with respiratory compromise, or advanced multiple sclerosis with significant systemic effects. These cases often require high-acuity medical management, complex diagnostics, and multidisciplinary inpatient care resources. This Diagnosis-Related Group matters for Medicare payment because the presence of a Major Complication or Comorbidity increases relative resource use and affects reimbursement classification under Medicare inpatient prospective payment systems.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute neuroprotective and complication-management studies: randomized or controlled studies testing acute inpatient interventions aimed at reducing immediate neurologic deterioration or managing life-threatening complications in patients hospitalized with advanced degenerative nervous system disorders (for example, interventions targeting swallowing dysfunction, aspiration risk, autonomic instability, or acute exacerbations of motor symptoms). These trials typically enroll patients during hospital admission, often with high comorbidity burden and multiple organ support needs, and are relevant because short-term intervention success can directly affect length of stay, ICU utilization, and the need for procedures that drive reimbursement and resource allocation.
    • Comparative effectiveness and care pathway trials across disease severity: pragmatic trials comparing different inpatient and transitional care pathways (for example, multidisciplinary neurology-physical therapy models versus standard care, or early palliative integration versus usual timing) in populations with advanced degenerative neurologic conditions and major complications (the MCC population). These studies examine outcomes such as functional status at discharge, readmission rates, complications, and cost per episode; they are important to providers and payers because they identify which care models reduce costly complications and downstream resource use for this high-acuity DRG group.
    • Post-discharge outcomes and readmission-prevention studies: longitudinal cohort studies or interventional trials focused on transitional care interventions (care coordination, home health intensity, telemonitoring) targeting patients recently discharged after hospitalization for degenerative nervous system disorders with significant comorbidity. These studies enroll the same high-risk patients captured under this DRG to measure 30- and 90-day readmissions, emergency department utilization, functional decline, and caregiver burden; findings inform reimbursement incentives, case management strategies, and value-based payment decisions aimed at reducing readmissions and total cost of care.

    Related Codes

    020-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

    021-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-CC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

    022-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITHOUT-CC-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

    023-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITH-MCC-OR-ANTINEOPLASTIC-IMPLANT-OR-EPILEPSY-WITH-NEUROSTIMULATOR

    Craniotomy with Major Device Implant or Complex CNS DRG 023: Inpatient Reimbursement Overview

    024-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITHOUT-MCC

    Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC: Inpatient Reimbursement Overview

    025-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-MCC

    Craniotomy and Endovascular Intracranial Procedures with MCC: Inpatient Reimbursement Overview

    026-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-CC

    Craniotomy and Endovascular Intracranial Procedures with CC: Inpatient Reimbursement Overview

    027-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITHOUT-CC-MCC

    Craniotomy and Endovascular Intracranial Procedures without CC/MCC: Inpatient Reimbursement Overview

    028-SPINAL-PROCEDURES-WITH-MCC

    Spinal Procedures with MCC: Inpatient Reimbursement Overview

    029-SPINAL-PROCEDURES-WITH-CC-OR-SPINAL-NEUROSTIMULATORS

    Spinal Procedures with CC or Spinal Neurostimulators: Inpatient Reimbursement Overview

    Showing 1–10 of 71

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.